News

Contract Pharma: 'A Modern CDMO' Article

Quotient Sciences' Head of Drug Substance, Paul Quigley, recently shared his thoughts on the importance of flexibility, collaboration and innovation for the modern CDMO. In his article for Contract Pharma, Paul explains the greater need for more effective process solutions during drug development and how successful contract service organisations are meeting this challenge. He also defines the Quotient Sciences model for accelerated delivery, through integrated services and technological innovation.

Access the article here: https://www.contractpharma.com/issues/2019-05-01/view_features/the-modern-cdmo/

We use cookies to help us to improve our site and enables us to the best possible service and customer experience. By clicking accept you are agreeing to let us share your data with select third parties for analytics and marketing purposes.